| N06AX16 |
Venlafaxine |
TIFAXIN SR |
Prolonged release capsule, hard |
150 |
mg |
30 |
Stada Arzneimittel AG, Германия |
100 |
mg |
- |
29.1 |
0.15578 |
7.01 |
50% |
3.51 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№100/23.08.2010; НСР-2568/24.01.2014 |
02.03.2014 |
08.09.2012 |
16.11.2013 |
Заличен |
889 |
| N06AX16 |
Venlafaxine |
VELAXIN |
Prolonged release capsule, hard |
75 |
mg |
28 |
EGIS Pharmaceuticals PLC, Унгария |
100 |
mg |
- |
10.85 |
0.35256 |
7.4 |
50% |
3.7 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КП-30/05.03.2015 и НСР-1566/25.10.2013; HCP-6026/09.04.2015. |
02.11.2018 |
08.09.2012 |
|
Активен |
3647 |
| N06AX16 |
Venlafaxine |
VELAXIN |
Prolonged release capsule, hard |
150 |
mg |
28 |
EGIS Pharmaceuticals PLC, Унгария |
100 |
mg |
- |
17.45 |
0.35256 |
14.81 |
50% |
7.4 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КП-30/05.03.2015 и НСР-1566/25.10.2013; HCP-6027/09.04.2015. |
02.11.2018 |
08.09.2012 |
|
Активен |
3648 |
| N06AX16 |
Venlafaxine |
Venlacon PR |
Prolonged release capsule, hard |
75 |
mg |
30 |
Фармаконс АД, България |
100 |
mg |
- |
16.09 |
0.35256 |
7.93 |
50% |
3.96 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
НСР-13736/12.09.2017 |
02.11.2018 |
|
|
Активен |
15840 |
| N06AX16 |
Venlafaxine |
Venlafectin |
Prolonged release capsule, hard |
150 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
100 |
mg |
- |
60.84 |
0.24178 |
10.88 |
50% |
5.44 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-1195/13.08.2012 г.; НСР-12312/07.04.2017 |
02.05.2017 |
08.09.2012 |
|
Заличен |
1336 |
| N06AX16 |
Venlafaxine |
Venlafectin |
Prolonged release capsule, hard |
75 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
100 |
mg |
- |
31.73 |
0.24178 |
5.44 |
50% |
2.72 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-1198/13.08.2012 г.; НСР-12312/07.04.2017 |
02.05.2017 |
08.09.2012 |
|
Заличен |
1337 |
| N06AX17 |
Milnacipran |
N06AX17 Milnacipran |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N06AX17 |
Milnacipran |
IXEL |
Capsule, hard |
50 |
mg |
56 |
Pierre Fabre Medicament, Франция |
100 |
mg |
- |
36.38 |
1.29929 |
36.38 |
50% |
18.19 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№20/15,07,2009 г.; КЦРР-2792/20.03.2013; НСР-642/29.07.2013; НСР-3108/26.03.2014; НСР-5140/27.11.2014.; НСР-6831/30.07.2015.; НСР-8578/24.03.2016.; НСР-11653/03.02.2017 г. |
02.03.2017 |
08.09.2012 |
|
Заличен |
3394 |
| N06AX17 |
Milnacipran |
IXEL |
Capsule, hard |
25 |
mg |
28 |
Pierre Fabre Medicament, Франция |
100 |
mg |
- |
14.96 |
2.13714 |
14.96 |
50% |
7.48 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№20/15,07,2009 г.; НСР-6825/30.07.2015.; НСР-18156/07.03.2019 |
02.04.2019 |
08.09.2012 |
|
Заличен |
721 |
| N06AX18 |
Reboxetine |
N06AX18 Reboxetine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N06AX18 |
Reboxetine |
Edronax |
Tablet |
4 |
mg |
60 |
Pfizer Europe MA EEIG, Обединено Кралство |
8 |
mg |
- |
29.53 |
0.98433 |
29.53 |
50% |
14.77 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
НСР-7333/29.10.2015 |
02.12.2015 |
08.09.2012 |
|
Заличен |
658 |
| N06AX18 |
Reboxetine |
Edronax |
Tablet |
4 |
mg |
20 |
Pfizer Europe MA EEIG, Обединено Кралство |
8 |
mg |
- |
19.52 |
0.98433 |
9.84 |
50% |
4.92 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-1071/26.07.2012 г.; НСР-2231/20.12.2013 |
16.01.2014 |
08.09.2012 |
|
Заличен |
1357 |
| N06AX21 |
Duloxetine |
N06AX21 Duloxetine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N06AX21 |
Duloxetine |
Aritavi |
Gastro resistant capsule, hard |
60 |
mg |
28 |
Actavis Group PTC ehf., Исландия |
60 |
mg |
- |
21.77 |
0.45 |
12.6 |
50% |
6.3 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-7496/13.11.2015.; НСР-14844/18.01.2018; НСР-18277/28.03.2019 |
02.05.2019 |
|
|
Активен |
4099 |
| N06AX21 |
Duloxetine |
Aritavi |
Gastro resistant capsule, hard |
30 |
mg |
28 |
Actavis Group PTC ehf., Исландия |
60 |
mg |
- |
13.88 |
0.45 |
6.3 |
50% |
3.15 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-7496/13.11.2015.; НСР-14843/18.01.2018; НСР-18276/28.03.2019 |
02.05.2019 |
|
|
Активен |
4098 |
| N06AX21 |
Duloxetine |
Dulasolan |
Gastro resistant capsule, hard |
60 |
mg |
30 |
G. L. Pharma GmbH, Австрия |
60 |
mg |
- |
13.5 |
0.45 |
13.5 |
50% |
6.75 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-8042/08.02.2016.; НСР-13156/17.07.2017; НСР-16964/12.10.2018 |
02.11.2018 |
|
|
Активен |
4181 |
| N06AX21 |
Duloxetine |
Dulasolan |
Gastro resistant capsule, hard |
30 |
mg |
30 |
G. L. Pharma GmbH, Австрия |
60 |
mg |
- |
15.35 |
0.45 |
6.75 |
50% |
3.37 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-8042/08.02.2016.; НСР-13155/17.07.2017 |
02.11.2018 |
|
|
Активен |
4180 |
| N06AX21 |
Duloxetine |
Dulodet |
Gastro resistant capsule, hard |
30 |
mg |
28 |
EGIS Pharmaceuticals PLC, Унгария |
60 |
mg |
- |
21.62 |
0.45 |
6.3 |
50% |
3.15 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-8536/16.03.2016; НСР-13207/17.07.2017; НСР-16962/12.10.2018 |
02.11.2018 |
|
|
Активен |
4200 |
| N06AX21 |
Duloxetine |
Dulodet |
Gastro resistant capsule, hard |
60 |
mg |
28 |
EGIS Pharmaceuticals PLC, Унгария |
60 |
mg |
- |
21.48 |
0.45 |
12.6 |
50% |
6.3 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-14309/26.10.2017 и НСР-14314 (предварително изпълнение) |
02.11.2018 |
|
|
Активен |
15912 |
| N06AX21 |
Duloxetine |
Duloxetine Alvogen |
Gastro resistant capsule, hard |
30 |
mg |
30 |
Alvogen IPCo S.àr.l, Люксембург |
60 |
mg |
- |
15.22 |
0.45 |
6.75 |
50% |
3.37 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9108/27.04.2016.; НСР-16335/02.08.2018; НСР-18072/01.03.2019 |
02.04.2019 |
|
|
Заличен |
15020 |
| N06AX21 |
Duloxetine |
Duloxetine Alvogen |
Gastro resistant capsule, hard |
60 |
mg |
30 |
Alvogen IPCo S.àr.l, Люксембург |
60 |
mg |
- |
29.69 |
0.45 |
13.5 |
50% |
6.75 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9108/27.04.2016.; НСР-16334/02.08.2018; НСР-18071/01.03.2019 |
02.04.2019 |
|
|
Заличен |
15017 |
| N06AX21 |
Duloxetine |
Duloxgamma |
Gastro resistant capsule, hard |
30 |
mg |
28 |
Woerwag Pharma GmbH & Co.KG, Германия |
60 |
mg |
- |
22.5 |
0.45 |
6.3 |
50% |
3.15 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9125/27.04.2016.; НСР-16351/02.08.2018 |
02.11.2018 |
|
|
Активен |
15027 |
| N06AX21 |
Duloxetine |
Duloxgamma |
Gastro resistant capsule, hard |
60 |
mg |
28 |
Woerwag Pharma GmbH & Co.KG, Германия |
60 |
mg |
- |
26.15 |
0.45 |
12.6 |
50% |
6.3 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9125/27.04.2016.; НСР-16350/02.08.2018 |
02.11.2018 |
|
|
Активен |
15028 |
| N06AX21 |
Duloxetine |
Duloxi |
Gastro resistant capsule, hard |
30 |
mg |
x 28 |
Фармаконс АД, България |
60 |
mg |
- |
14.18 |
0.45 |
6.3 |
50% |
3.15 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9648/23.06.2016; НСР-16819/20.09.2018 |
02.11.2018 |
|
|
Активен |
15307 |
| N06AX21 |
Duloxetine |
Duloxi |
Gastro resistant capsule, hard |
60 |
mg |
30 |
Фармаконс АД, България |
60 |
mg |
- |
29.69 |
0.45 |
13.5 |
50% |
6.75 |
|
F31.3,F31.4,F31.5,F33.0,F33.1,F33.2,F33.3,G63.2 |
НСР-9805/14.07.2016; НСР-16820/20.09.2018 |
02.11.2018 |
|
|
Активен |
15298 |